VanEck Biotech ETF Rating $157.91 -7.22 (-4.37%) (As of 11/15/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy2.66Holdings in BBH have an aggregate rating of Moderate Buy based on 481 analyst ratings issued in the past year covering 25 companies (99.9% of the portfolio).BBH Aggregate Price Target$157.91High Prediction$157.91Average Prediction$157.91Low Prediction$157.91Holdings in BBH have an aggregate price target of $157.91 and a range of $157.91 to $157.91 covering 25 companies (99.9% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.76%AMGNAmgen$283.61-4.2%4.9214 of 5 stars2.46$333.57 17.6%26Analyst ForecastShort Interest ↓News CoveragePositive NewsHigh Trading Volume10.28%VRTXVertex Pharmaceuticals$465.70-3.8%3.5494 of 5 stars2.53$499.12 7.2%30Analyst UpgradeNews CoveragePositive NewsHigh Trading Volume9.77%GILDGilead Sciences$88.40-4.0%4.6269 of 5 stars2.68$93.86 6.2%25Analyst UpgradeShort Interest ↑News Coverage7.85%REGNRegeneron Pharmaceuticals$756.81-3.3%4.8088 of 5 stars2.78$1,099.55 45.3%23Analyst UpgradeNews Coverage4.97%IQVIQVIA$192.68-5.1%4.9877 of 5 stars2.84$259.13 34.5%19News CoveragePositive NewsHigh Trading Volume4.83%ARGXargenx$564.23-5.2%2.8645 of 5 stars2.91$619.79 9.8%23Analyst UpgradeGap DownHigh Trading Volume4.47%ICLRICON Public$189.64-5.2%4.7116 of 5 stars2.86$304.27 60.4%14Short Interest ↓News Coverage4.12%ILMNIllumina$135.05-5.1%4.3793 of 5 stars2.67$164.00 21.4%24Analyst ForecastPositive NewsHigh Trading Volume4.10%BIIBBiogen$159.99-3.0%4.8908 of 5 stars2.57$258.96 61.9%28Analyst UpgradeNews Coverage3.77%ALNYAlnylam Pharmaceuticals$235.56-8.7%4.8183 of 5 stars2.71$294.50 25.0%24Analyst DowngradeShort Interest ↓3.12%MRNAModerna$36.85-7.3%4.5668 of 5 stars2.05$90.22 144.8%21Analyst ForecastOptions VolumeGap DownHigh Trading Volume2.69%NTRANatera$146.06-3.3%2.854 of 5 stars3.00$137.65 -5.8%17Earnings ReportAnalyst ForecastInsider SellingAnalyst RevisionNews Coverage2.33%BNTXBioNTech$99.72-3.7%3.521 of 5 stars2.79$137.54 37.9%14Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap DownHigh Trading Volume2.11%EXASExact Sciences$49.33-3.1%4.862 of 5 stars2.95$74.47 51.0%19Insider BuyingShort Interest ↓2.07%INSMInsmed$66.29-7.0%4.4008 of 5 stars3.00$83.07 25.3%16Positive NewsHigh Trading Volume2.02%NBIXNeurocrine Biosciences$117.44-4.4%4.9651 of 5 stars2.83$163.91 39.6%24Positive News1.96%BMRNBioMarin Pharmaceutical$63.42-3.3%4.987 of 5 stars2.74$94.20 48.5%23Analyst ForecastInsider SellingNews Coverage1.96%SRPTSarepta Therapeutics$104.54-4.2%4.929 of 5 stars3.00$181.33 73.5%22Analyst Upgrade1.94%BGNEBeiGene$189.23-2.1%3.0621 of 5 stars2.71$247.07 30.6%7Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage1.92%TECHBio-Techne$67.57-6.9%4.7403 of 5 stars2.67$81.78 21.0%9Analyst UpgradeHigh Trading Volume1.73%QGENQiagen$41.27-1.9%4.2971 of 5 stars2.60$50.88 23.3%10Analyst Revision1.70%CRLCharles River Laboratories International$187.74-4.7%4.7735 of 5 stars2.00$217.54 15.9%15Insider SellingShort Interest ↓1.39%INCYIncyte$75.87-2.4%4.1889 of 5 stars2.38$77.16 1.7%21Analyst ForecastPositive News1.22%RGENRepligen$124.73-12.4%4.6434 of 5 stars2.73$190.25 52.5%11Earnings ReportAnalyst UpgradeAnalyst RevisionNews CoverageHigh Trading Volume0.86%CYTKCytokinetics$50.22-8.2%3.8651 of 5 stars2.75$83.67 66.6%16Insider SellingHigh Trading Volume This page (NASDAQ:BBH) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBH Stock Alerts